U TNO Quality of Life Research Institute and at Leiden Amsterdam Centre for Drug Research at Leiden University.
Brief Bioinform. 2010 Jul;11(4):403-16. doi: 10.1093/bib/bbp071. Epub 2010 Jan 7.
This article provides methodological and technical considerations to researchers starting to develop computational model-based diagnostics using clinical chemistry data. These models are of increasing importance, since novel metabolomics and proteomics measuring technologies are able to produce large amounts of data that are difficult to interpret at first sight, but have high diagnostic potential. Computational models aid interpretation and make the data accessible for clinical diagnosis. We discuss the issues that a modeller has to take into account during the design, construction and evaluation phases of model development. We use the example of Particle Profiler development, a model-based diagnostic tool for lipoprotein disorders, as a case study, to illustrate our considerations. The case study also offers techniques for efficient model formulation, model calculation, workflow structuring and quality control.
本文为刚开始使用临床化学数据开发基于计算模型的诊断方法的研究人员提供了方法学和技术方面的考虑。这些模型越来越重要,因为新型代谢组学和蛋白质组学测量技术能够产生大量数据,这些数据乍一看很难解释,但具有很高的诊断潜力。计算模型有助于解释,并使数据可用于临床诊断。我们讨论了建模者在模型开发的设计、构建和评估阶段必须考虑的问题。我们使用脂蛋白紊乱的基于模型的诊断工具 Particle Profiler 的开发为例来说明我们的考虑。该案例研究还提供了用于有效建模、模型计算、工作流程构建和质量控制的技术。